ERC Homebuilders 8% Dividend Opens, InSituBiologics Expands into the Veterinary MarketBlog
investors in the BFR market. We have a $2 billion backlog in requests from our ... biotech company focusing on the development of AnestaGel™, a long-acting ... they are preparing the FDA package for Phase 1 Clinical Study. The company has ...